Concepedia

Sik-Kwan Chan

SC

Statistics

Publications

3

Citations

89

H-Index

3

Active since

2020

Affiliations

University of Hong Kong(Current)

University of Hong Kong - Shenzhen Hospital

Sik-Kwan Chan is an author at University of Hong Kong specializing in oncology, pembrolizumab therapy, and distant metastasis staging.

Publications per year

2020–2021

3

Publications

3

Cost-effectiveness of Pembrolizumab as a Second-Line Therapy for Hepatocellular Carcinoma

Chi‐Leung Chiang, Sik-Kwan Chan, Shing Fung Lee et al. · JAMA Network Open · 2021 · 54 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy

Sik-Kwan Chan, Sum‐Yin Chan, Cheuk‐Wai Choi et al. · Frontiers in Oncology · 2020 · 18 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinoma: A pooled analysis of two prospective studies

Sik-Kwan Chan, Sum‐Yin Chan, Chi‐Chung Tong et al. · Oral Oncology · 2021 · 17 citations

Medicine, Oncology, Pharmacology +15

1–3 of 3